Class I and class II major histocompatibility complex genes in Mexican patients with actinic prurigo.
British Journal of Dermatology (Impact Factor: 3.76). 06/2007; 156(5):1074-5. DOI:10.1111/j.1365-2133.2007.07801.x
Article: Actinic prurigo: an update.International Journal of Dermatology 07/1995; 34(6):380-4. · 1.34 Impact Factor
- International Journal of Dermatology 04/1975; 14(2):105-11. · 1.34 Impact Factor
- [show abstract] [hide abstract]
ABSTRACT: Human leukocyte antigen (HLA) DRB1*0407 had been associated with actinic prurigo in different populations. This class II HLA-DR subtype had not been studied in Colombia. The objective of this study was to establish whether there was an association of actinic prurigo with HLA DR in a Colombian population. Forty patients with a clinical diagnosis of actinic prurigo and 40 healthy subjects, paired by age, sex and birthplace, were studied. HLA typing for HLA DRB1 and DRB1*04, if necessary, was performed by the PCR-SSP method using blood samples. A high frequency of HLA DRB1*0407 was found in the patients (97.5% vs. 30%; P<0.00001). The allelic frequency of HLA DRB1*0407 was 63.8% in the case group, and 14.5% in the controls (P<0.00001). In the control group, there was a higher frequency of the alleles DRB1*01 (14.5% vs. 1.25%; P=0.0027) and DRB1*13 (23.7% vs. 2.5%; P=0.00013). The small number of controls does not allow us to drive conclusions about other HLA alleles. HLA subtype DRB1*0407, found in actinic prurigo patients in studies conducted in England, Scotland, Ireland and Mexico, was also associated in Colombian patients. This finding, concordant in patients from different ethnic groups, could be helpful in the diagnosis of this disease and probably important in its pathogenesis. DRB1*01 and DRB1*13 alleles were more frequent in controls than in patients; we do not know whether they play any role in the resistance to the disease.Photodermatology Photoimmunology and Photomedicine 04/2006; 22(2):55-8. · 1.52 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.